How much does the Sanford Guide app cost?

How much does the Sanford Guide app cost?

The Sanford Guide mobile app ($39.99/yr In-App subscription) includes all the information you've come to expect from our print guide, with expanded digital-only content and numerous interactive features that make it an indispensable resource for today's medical professionals.

WHO publishes the Sanford Guide?

The Sanford Guides are published by: ANTIMICROBIAL THERAPY, INC. All rights reserved.

What is antimicrobial therapy?

Definition. An antimicrobial therapy kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans. Therapies that kill microorganisms are called microbiocidal therapies and therapies that only inhibit the growth of microorganisms are called microbiostatic therapies.

How do you use the Sanford Guide?

https://www.youtube.com/watch?v=JNPgL1exK08

How do I cite the Sanford Guide Web Edition?

- MLA. The Sanford Guide to Antimicrobial Therapy. Dallas, TX :Antimicrobial Therapy, Inc., 1995. - APA. The Sanford guide to antimicrobial therapy. ( 1995). Dallas, TX :Antimicrobial Therapy, Inc., - Chicago. “The Sanford Guide to Antimicrobial Therapy.” Dallas, TX :Antimicrobial Therapy, Inc., 1995.

What's antimicrobial treatment?

Medicines used to treat infection are called antimicrobials. They include medicines for treating bacterial infections (antibiotics), fungal infections, viral infections and parasitic infections.18 Aug 2015

What is an example of an antimicrobial drug?

They include penicillin G, procaine penicillin, benzathine penicillin, and penicillin V. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases, such as syphilis, and infections caused by staphylococci and streptococci.

What is the main goal of antimicrobial treatment?

The goal of antimicrobial therapy is, therefore, to eradicate bacteria at the site of infection. Bacterial eradication is not usually assessed as a primary endpoint within the limits of currently recommended clinical trial design.